Chlamydia trachomatis, the bacterial culprit behind Chlamydia infections, presents a global public health challenge. This sexually transmitted infection (STI) is pervasive, affecting millions of individuals worldwide, with a disproportionately high incidence among young adults. The complex interplay of social, cultural, and economic factors contributes to its prevalence, highlighting the need for multifaceted interventions. Chlamydia's insidious nature, often asymptomatic in the early stages, exacerbates the challenge of containment. The infection's impact extends beyond immediate health concerns, as it poses a significant risk for long-term complications, including infertility and increased susceptibility to other sexually transmitted diseases. This underscores the urgency of comprehensive prevention strategies, including education, routine screenings, and accessible healthcare. Global efforts to address Chlamydia infections involve a combination of awareness campaigns, policy advocacy, and research initiatives. Collaborative endeavors aim to standardize testing protocols, improve diagnostic tools, and develop vaccines to curb the spread of the infection. Additionally, initiatives focus on destigmatizing conversations around sexual health, fostering open communication, and empowering individuals to take charge of their well-being.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation